"That is very different from a drug actually causing a new cancer." Patients using GLP-1 therapy typically have more medical appointments, specialized care and diagnostic imaging
The mean duration of exposure to semaglutide or placebo in the study was 34.2 months
The numbers above are not from head-to-head clinical trials, as those do not exist yet
Both drugs can independently cause tachycardia (increased heart rate), and together they may compound this effect, increasing the risk of arrhythmias and other cardiac events
Most users have found their optimal dose, and the medication is working at full capacity
Weight loss depends on many different factors, including diet, exercise, and sleep habits